| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-102 |
| PharmacoGx | KIN001-102 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZNF429 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | FNDC3B | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | ETS1 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | INPP1 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | DYNLT3 | GDSC1000 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | TXNDC15 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | DENND1C | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | CASP8AP2 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | SERTAD2 | GDSC1000 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | SIDT1 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
